Enfortumab vedotin for previously treated locally advanced or metastatic urothelial cancer (terminated appraisal)
Technology appraisal
Reference number: TA797
Published:
The company has informed NICE that it will not provide an evidence submission for this appraisal.
Therefore, we are suspending the appraisal while we consider the next steps